CG Oncology, Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 680.26M | 661.05M | 688.43M | 742.00M | 540.71M |
| Total Receivables | 515.00K | 562.00K | 345.00K | 781.00K | 137.00K |
| Inventory | 1.50M | -- | -- | -- | -- |
| Prepaid Expenses | 13.51M | 11.42M | 12.41M | 11.43M | 11.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 695.79M | 673.03M | 701.19M | 754.21M | 552.08M |
|
|
|||||
| Total Current Assets | 695.79M | 673.03M | 701.19M | 754.21M | 552.08M |
| Net Property, Plant & Equipment | 19.53M | 1.22M | 1.30M | 493.00K | 338.00K |
| Long-term Investments | 12.81M | -- | -- | -- | -- |
| Goodwill | 12.81M | -- | -- | -- | -- |
| Total Other Intangibles | 1.67M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 114.00K | 27.20M | 25.69M | 94.00K | 53.00K |
| Total Assets | 729.91M | 701.45M | 728.18M | 754.80M | 552.47M |
|
|
|||||
| Total Accounts Payable | 9.19M | 7.13M | 6.73M | 6.52M | 4.08M |
| Total Accrued Expenses | 19.62M | 22.73M | 15.18M | 14.23M | 11.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 912.00K | 288.00K | 255.00K | 186.00K | 225.00K |
| Total Finance Division Other Current Liabilities | 803.00K | 241.00K | 481.00K | 436.00K | 221.00K |
| Total Other Current Liabilities | 803.00K | 241.00K | 481.00K | 436.00K | 221.00K |
| Total Current Liabilities | 30.53M | 30.38M | 22.64M | 21.37M | 15.63M |
|
|
|||||
| Total Current Liabilities | 30.53M | 30.38M | 22.64M | 21.37M | 15.63M |
| Long-Term Debt | 3.00M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.33M | 706.00K | 781.00K | 52.00K | 71.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.41M | -- | -- | -- | -- |
| Total Liabilities | 42.27M | 31.09M | 23.42M | 21.42M | 15.70M |
|
|
|||||
| Common Stock & APIC | 1.03B | 964.22M | 957.19M | 951.36M | 722.95M |
| Retained Earnings | -337.67M | -293.86M | -252.43M | -217.98M | -186.18M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 687.64M | 670.36M | 704.76M | 733.38M | 536.77M |
|
|
|||||